References
- Dirksen U, Moghadam KA, Mambetova C, et al. (2004). Glutathione S-transferase theta 1 gene (GSTT1) null genotype is associated with an increased risk for acquired aplastic anemia in children. Pediatr Res 55:466–71
- Dufour C, Svahn J, Bacigalupo A, et al. (2005). Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anemia in Caucasian patients. Haematologica 90:1027–31
- Erkisi Z, Yaylim-Eraltan I, Turna A, et al. (2010). Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis. Tumori 96:756–63
- Gresner P, Gromadzinska J, Wasowicz W. (2007). Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 57:1–25
- Gupta V, Pratap R, Kumar A, et al. (2013). Epidemiological features of aplastic anemia in Indian children. Indian J Pediatr 81:257–9
- Gurion R, Gafter-Gvili A, Paul M, et al. (2009). Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy – systematic review and meta-analysis. Haematologica 94:712–19
- Huang WY, Chatterjee N, Chanock S, et al. (2005). Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 14:152–7
- Kamal MA, Elsaadany ZA, Makhlouf MM, et al. (2012). Genetic polymorphism of microsomal epoxide hydrolase enzyme gene in preeclamptic females. Am J Med Sci 343:291–4
- Kiran M, Chawla YK, Kaur J. (2008). Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India. DNA Cell Biol 27:687–94
- Lin TS, Huang HH, Fan YH, et al. (2007). Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer. Oncol Rep 17:565–72
- Marsh JC, Ball SE, Cavenagh J, et al. (2009). Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 147:43–70
- Ozhan G, Alpertunga B. (2006). Polymorphism of microsomal epoxide hydrolase. Adv Mol Med 2:109–11
- Poonkuzhali B, Shaji RV, Salamun DE, et al. (2005). Cytochrome P4501A1 and glutathione S-transferase gene polymorphisms in patients with aplastic anemia in India. Acta Haematol 114:127–32
- Sang Q, Li X, Wang H, et al. (2014). Quantitative methylation level of the EPHX1 promoter in peripheral blood DNA is associated with polycystic ovary syndrome. PLoS One 9:e88013–7
- Sarmanova J, Benesova K, Guti I, et al. (2001). Genetic polymorphism of biotransformation enzymes with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet 10:1265–73
- Srivastava DS, Mandhani A, Mittal RD. (2008). Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India. Arch Toxicol 82:633–9
- Tan X, He WW, Wang YY, et al. (2014). EPHX1 Tyr113His and His139Arg polymorphisms in esophageal cancer risk: a meta-analysis. Genet Mol Res 13:649–59
- Ulrich CM, Bigler J, Whitton JA, et al. (2001). Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 10:875–82
- Yang X, Liang S, Weyant D, et al. (2009). The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter. J Pharmacol Exp Ther 330:23–30
- Young NS. (2000). Hematopoietic cell destruction by immune mechanisms in acquired aplastic anemia. Semin Hematol 37:3–14
- Young NS, Scheinberg P, Calado RT. (2008). Aplastic anemia. Curr Opin Hematol 15:162–8
- Youssry I, Hammoud R, Ibrahim O, et al. (2011). Genetic polymorphisms of glutathione-S-transferase and microsomal epoxide hydrolase in Egyptian acquired aplastic anemia patients. J Pediatr Hematol Oncol 33:89–92